Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Androgens Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2017

Prostatic Neoplasms
Radiotherapy
Observation
Radiation
Therapeutics

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])

Pili, R., Jegede, O., Carducci, M. A., Manola, J., Groteluschen, D. L., Appleman, L. L., Liu, G., Shanks, J. C., Dakhil, S. R., Dutcher, J. & DiPaola, R. S. Jan 5 2017 (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Research - peer-reviewArticle

Renal Cell Carcinoma
aflibercept
Disease Progression
Therapeutics
Vascular Endothelial Growth Factor Receptor

A review of pomegranate in prostate cancer

Paller, C. J., Pantuck, A. & Carducci, M. A. Sep 1 2017 In : Prostate Cancer and Prostatic Diseases. 20, 3, p. 265-270 6 p.

Research output: Research - peer-reviewReview article

Punicaceae
Prostatic Neoplasms
Recurrence
Placebos
Dietary Supplements
Circulating Neoplastic Cells
Castration
Androgen Receptors
Prostatic Neoplasms
Messenger RNA

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: A multicentre, single-arm phase I/II clinical trial

Pili, R., Liu, G., Chintala, S., Verheul, H., Rehman, S., Attwood, K., Lodge, M. A., Wahl, R., Martin, J. I., Miles, K. M., Paesante, S., Adelaiye, R., Godoy, A., King, S., Zwiebel, J. & Carducci, M. A. Mar 28 2017 In : British Journal of Cancer. 116, 7, p. 874-883 10 p.

Research output: Research - peer-reviewArticle

Phase II Clinical Trials
Clinical Trials, Phase I
Histone Deacetylase Inhibitors
Renal Cell Carcinoma
vorinostat